Chlormadinone acetate (CMA) in oral contraception - A new opportunity

European Journal of Contraception and Reproductive Health Care

Volumn 10, Issue SUPPL. 1, 2005, Pages 7-11

  Bouchard, P ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Belara ; Chlormadinone acetate; Contraception; Ethinylestradiol; Oral contraceptive

Indexed keywords

ALBUMIN; ANDROGEN; ANDROGEN RECEPTOR; CHLORMADINONE ACETATE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; ESTROGEN; GONADOTROPIN; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE;

ADRENAL GLAND; ANDROGEN SYNTHESIS; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; ENDOMETRIUM; ENZYME ACTIVITY; FOLLICULAR PHASE; GONADOTROPIN RELEASE; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; INHIBITION KINETICS; LIVER CANCER; METABOLIC PARAMETERS; MULTIPLE DRUG DOSE; NONHUMAN; ORAL CONTRACEPTION; OVARY; OVARY FOLLICLE MATURATION; OVULATION INHIBITION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEADY STATE; TARGET ORGAN; THROMBOEMBOLISM; UTERINE CERVIX MUCUS; VENOUS THROMBOEMBOLISM; VISCOSITY;

ANDROGEN ANTAGONISTS; AREA UNDER CURVE; CHLORMADINONE ACETATE; CLINICAL TRIALS; CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION;

EID: 29044448524     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180500434889     Document Type: Conference Paper

References (29)

1. Fraser IS, Lobo R (eds). Update on progestogen therapy. J Reprod Med 1999;44:139-232.
2. Bell ET, Christie BW. Gonadotrophin and steroid interrelationships during the normal menstrual cycle. Steroidologia 1970;1:152-74.
3. O'Malley BW, Sherman MR, Toft DO. Progesterone "receptors" in the cytoplasm and nucleus of chick oviduct target tissue. Proc Natl Acad Sci USA 1970;67:501-8.
4. Edwards DP, Weigel NL, Schrader WT, O'Malley BW, McGuire WL. Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein. Biochemistry 1984;23:4427-35.
5. O'Malley BW. A life-long search for the molecular pathways of steroid hormone action. Mol Endocrinol 2005;19:1402-11.
6. O'Malley BW, Schrader WT. Progesterone receptor components: identification of subunits binding to the target-cell genome. J Steroid Biochem 1972;3:617-29.
7. Giangrande PH, McDonnell DP. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog Horm Res 1999;54:291-313.
8. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993;7:1244-55.
9. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 1994;14:8356-64.
10. Leo JC, Guo C, Woon CT, Aw SE, Lin VC. Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology 2004;145:1314-21.
11. Dorfman RI, Forchielli E, Gut M. Androgen biosynthesis and related studies. Recent Progr Hormone Res 1963;19:251-73.
12. Kraft HG, Kiesler H. Anti-estrogenic and anti-androgenic activities of chlormadinone acetate and related compounds. In: James VHT, Martini L (eds). Hormonal Steroids. Proceedings of the Second International Congress on Hormonal Steroids, Milano. Excerpta Medica, 1966.
13. Kuhl H. Chemie und Pharmakologie von Chlormadinoneacetat. In: Loch EG, Schramm G (eds.). Chlormadiononeacetat bei Androgenisierungserscheinungen. Schattauer 1995:1-12.
14. Saunders DM, Stewart ML, Brij BS, et al. Effect of daily administration of 0.5 mg of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle. Fertil Steril 1971;22:332-44.
15. Orr AH, Elstein M. Luteinizing hormone levels in plasma and urine in women during normal menstrual cycles and in women taking combined contraceptives or chlormadinone acetate. J Endocrinol 1969;43:617-24.
16. Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas 1990; 12:171-97.
17. Larsson-Cohn U, Johansson ED, Wide L, et al. Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. Acta Endocrinol (Copenh) 1970;63:705-16.
18. Raudrant D, Rabe T. Progestogens with antiandrogenic properties. Drugs 2003;63:463-92.
19. Grünenthal GmbH. Belara®: Highlights of the product's properties. Product Monograph. Aachen, 2001.
20. Gallegos AJ, Gonzalez-Diddi M, Merino G, et al. Tissue localization of radioactive chlormadinone acetate and progesterone in the human. Contraception 1970;1:151-61.
21. Honma S, Iwamura S, Iizuka K, Kambegawa A, Shida K. Identification and anti-androgenic activity of the metabolites of 17alpha-acetoxy-6-chloropregna-4, 6-diene-3,20-dione (chlormadinone acetate) in the rat, rabbit, dog and man. Chem Pharm Bull (Tokyo) 1977;25:2019-31.
22. Chassard D, Legallicier P, Dib M. Etude de la biodisponibilite relative de deux formations orales d'acetate de chlormadinone: Luteran 5mg and Luteran comprime dose a 10 mg. Therapie 2003;58:127-31.
23. Terlinden R, Uragg H, Göhler K, Kneip C. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg), poster presented at SEG 2005, Helsinki.
24. Kuhl H, Jung-Hoffmann C. Pharmakologie der Gestagene. In: Kuhl H, Jung-Hoffmann C (eds.). Kontrazeption. Stuttgart: Thieme, 1999:28-31.
25. Pélisser C, Blacker MC, Feinstein MC, Cournot A, Dennis C. Anti-ovulatory action of chlormadinone acetate [in French]. Contracept Fertil Sex 1994;22:37-40.
26. Chassard D, Schatz B. The antigonadotrophic activity of chlormadinone acetate in reproductive women [in French]. Gynecol Obstet Fert 2005;33:29-35.
27. Johnson AN. Comparative aspects of contraceptive steroids - effects observed in beagle dogs. Toxicol Pathol 1989;17:389-95.
28. Conard J, Plu-Bureau G, Bahi N, Horellou MH, Pélisser C, Thalabard JC. Progestogen-only contraception in women at high risk of thromboembolism. Contraception 2004;70:437-40.
29. Pélisser C, Basdevant A, Conard J, et al. Long-lasting administration of chlormadinone acetate effects on the metabolism, blood pressure and hormones. Gynécologie 1991;42:79-86.